7 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... anticoagulants (DOACs ... ) for VTE treatment ... #Anticoagulation ... #Pharmacology #
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents ... #DOAC #Dosing #Oral ... #Anticoagulation ... #Pharmacology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
direct-acting oral ... direct-acting oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... Management #Hematology #Oncology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Fondaparinux, and Novel Oral ... subcutaneous) and oral ... the mainstay of VTE ... the parenteral agents ... a traditional oral
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... Management #Hematology #Oncology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... cirrhosis) • Oral ... steroids, on ASA/anticoagulation ... #Ladder #medications ... #pharmacology #
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... neuroexam - Oral ... event, follow ACC algorithm ... Anticoagulation ... • <3mo since VTE